Division of Viral Hepatitis (EIS 2020)

The Division of Viral Hepatitis (DVH), in collaboration with U.S. and global partners, provides the scientific and programmatic foundation and leadership for the prevention and control of viral hepatitis infections and their manifestations. DVH has a broad scope of domestic and global activities, including exciting outbreak investigations; surveillance programs; analytic, cost- effectiveness, vaccination, and behavioral studies; and the prevention and control of blood-borne, enteric, sexual, and chronic diseases.

Areas of emphasis:

• Characterizing the epidemiology of hepatitis C virus infection (HCV), including nosocomial, perinatal, and sexual modes of transmission, along with HCV incidence among persons who inject drugs
• Developing new strategies to prevent HCV virus infection
• Preventing sequelae of chronic hepatitis B and C through early identification and management of cases
• Evaluating the performance of hepatitis A and hepatitis B vaccines and the impact of vaccination programs in the United States and overseas
• Characterizing the epidemiology of hepatitis A
• Evaluating the natural history and spectrum of chronic hepatitis B and C disease, access to care, and beneficial and adverse effects of evolving hepatitis therapy
• Defining morbidity and mortality due to chronic liver disease and liver cancer in the United States
• Addressing global health issues, including determining the burden of chronic liver disease, developing and evaluating strategies to prevent blood-borne infections related to unsafe injection practices, and evaluating strategies to improve hepatitis B vaccination programs in countries in the developing world

Carolyn Wester, MD, MPH

Director

Richard Davis, MS

Deputy Director

A. Blythe Ryerson, PhD, MPH

Associate Director for Science

Francisco Averhoff, MD, MPH

Associate Director for Global Health (EIS 1992)

Karina Rapposelli, MPH

Associate Director for Policy & Communication

Neil Gupta, MD, MPH

Chief, Epidemiology & Surveillance Branch (EIS 2010; Secondary EIS supervisor)

Noele Nelson, MD, PhD, MPH

Chief, Prevention Branch

Saleem Kamili, PhD

Chief, Lab Branch

Monique Aaron Foster, MD, MPH

(EIS 2014; Primary EIS supervisor)

Aaron Harris, MD, MPH

(EIS 2012; Secondary EIS supervisor)

Laura Cooley, MD, MPH

(EIS 2012)

Megan Hofmeister, MD, MS, MPH

(EIS 2016)

Ruth Jiles, PhD, MS, MPH

(EIS 1991)

Martha Montgomery, MD, MHS

(EIS 2016)

Muazzam Nasrullah, MD, MPH, PhD

(EIS 2018)

Sarah Schillie, MD, MPH, MBA

(EIS 2007)

Phil Spradling, MD

(EIS 1999)

Eyasu Teshale, MD

(EIS 2001)

Mark Weng, MD, MSc

(EIS 2016)